Thank you for sharing!

Your article was successfully shared with the contacts you provided.

Mary Buchanan lived a tragedy. In 1996, soon after the Food and Drug Administration approved a new Wyeth prescription weight loss drug called Redux, she began taking it. Redux stayed on the market for less than two years; Wyeth pulled the drug in 1997, after it became clear that Redux users had a significantly elevated risk of developing primary pulmonary hypertension, a potentially fatal disorder. That was too late for Mary Buchanan. She was diagnosed with primary pulmonary hypertension in 2001 and died of it in 2003.

Her estate continued to pursue the product liability and negligence suit she had filed against Wyeth (now part of Pfizer). The case was a complete failure at the federal district court level. In 2008 Cleveland federal district court Chief Judge Solomon Oliver Jr. granted summary judgment to Wyeth, finding Buchanan’s claim that Wyeth was negligent before the FDA approved Redux was pre-empted by the FDA’s approval of the drug. Her post-approval claims of strict liability, he found, failed on their merits.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]


ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.